ASX:RSH

Respiri (RSH) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.19 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
6.00%
Price Target
N/A

About Respiri

Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia. The company develops, produces, and sells mobile health applications. Its products include wheezo, an electronic wheeze detection tool to detect wheeze in children; respiri mobile application; and Respiri health portal. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. The company is based in Melbourne, Australia.

RSH Stock News Headlines

Better than Bitcoin? The Biotech Stock with 46,751% Potential
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
Why RadioShack (RSH) Stock Skyrocketed Today
Better than Bitcoin? The Biotech Stock with 46,751% Potential
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
Rush Uranium Corp. (RSH.CN)
Respiri (RSH): Initiation Objective measures for better outcomes
Respiri Limited (RSH.AX)
See More Headlines
Receive RSH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Respiri and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-6,390,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$772,196.00

Miscellaneous

Outstanding Shares
1,060,000,000
Free Float
N/A
Optionable
Not Optionable
Beta
-0.03
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Nicholas Smedley
    Executive Chairman
  • Mr. Marjan Mikel B.Sc.
    M.A.I.C.D., CEO, MD & Executive Director
  • Mr. Peter Hildebrandt
    Chief Operations Officer
  • Mr. George Vlachodimitropoulos
    Chief Technology Officer
  • Dr. Samaneh Sarraf Shirazi
    Chief Research Officer
  • Mr. Theo Antonopoulos
    Chief Commercial Officer
  • Mr. William Sigsbee
    Head of US Operations & Chief Commercial Officer
  • Mr. Justin Mouchacca B.Bus (Acc)
    C.A., CA, Joint Company Secretary
  • Ms. Nova Anne Taylor
    Joint Company Secretary
  • Prof. Noam Gavriely
    Medical & Scientific Advisor

This page (ASX:RSH) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners